Hints and tips:
Related Special Reports
...Lewis said he did not have “any formal involvement” with Morrisons or MFG....
...Glass Lewis branded increases to Soriot’s performance-linked pay package “excessive”....
...Carolyn Solan, head of external partnerships at consumer drugs group Haleon, which largely produces over-the-counter drugs that can be advertised more easily, said that “while partnering with expert patients...
...Glass Lewis and ISS also recommended shareholders oppose that plan....
...Another proxy adviser, Glass Lewis, has recommended clients support both Bock and von Bomhard....
...Kennedy Lewis, a $14bn credit firm, last week agreed to sell a significant stake to Petershill Partners, the private equity investment arm of Goldman Sachs Asset Management....
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
Investment bank and brokerage boosted by surging stock and fixed-income trading
...Leqembi, priced at $26,500 a year, was the first drug with a black-box warning — the most severe designation about possible side effects — to be granted full approval by the US Food and Drug Administration...
...The ruling came after Escobar Inc, the company set up by his brother, filed an application in 2021 with the European Union Intellectual Property Office (EUIPO) for registration of the word sign Pablo Escobar...
...So Leo, do you think Japan Inc, despite all this demographic stuff, has reason to be cautiously optimistic?...
Stocks in Tokyo on track to surpass all-time record reached in December 1989
...leo.lewis@ft.com...
More US-China decoupling in focus for investors as Tokyo market closes in on all-time high
...A top EU court has ruled that the name of the dead Colombian drug kingpin Pablo Escobar cannot be registered as a trademark in the EU....
...Marc FilippinoLeo Lewis is the FT’s Asia business editor. [MUSIC PLAYING] Marc FilippinoIn other market news, Reddit is gonna float....
...Japan’s trio of convenience store groups have fought each other on multiple fronts, with each increasing and improving their offerings of coffee, fast food, pre-prepared meals, drugs and exclusive goods....
...But it is a new generation of non-addictive painkillers that analysts say are the most promising drugs in Vertex’s pipeline....
...Nikkei Inc, which calculates and publishes the index, owns the Financial Times....
...Leo Lewis Yeah....
...Fellow proxy adviser Glass Lewis also highlighted Botín’s pay rise as a concern in its report seen by the FT, but backed the overall package because of the bank’s strong results....
...But within a year of the US Food and Drug Administration’s 2021 approval of the weight-loss drugs known as GLP-1 agonists, the threat of them breaking WW’s business model became clear....
Lenders in US, Asia and Europe hit by exposure to sector struggling with lower occupancy and higher interest rates
...But if the M&A deals of the 1980s were a demonstration of Japan Inc’s ambitions to take on the world, corporate executives say today’s overseas rush is driven by the need to find new revenue outside their...
...Then, GLP-1 anti-obesity drugs hit the market, long-time spokesperson and board member Oprah Winfrey announced her departure, and the company’s credit rating was downgraded....
International Edition